Last updated on August 2018

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Brief description of study

The aim of the study is to evaluate efficacy and safety of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with preserved ejection fraction

Clinical Study Identifier: NCT03057951

Contact Investigators or Research Sites near you

Start Over

Leobardo Valle Molina

Centro de Investigacion Clinica Acelerada, S.C.
Mexico, Mexico
  Connect »

José Luis Cervantes Escárcega

CEDOPEC-Ctro Esp en Diab, Obesidad y Prev de Enf Cardiovasc
México, Mexico
  Connect »

Manuel Enrique Aguilera Real

Centro de Investigacion Biomedica y Farmaceutica, S.C.
Distrito Federal, Mexico
  Connect »